评估COVID-19疫苗及其强剂量的可接受性
Sawsan Mubarak1, Ashraf A'aqoulah2,3, Hadeel AlGhawrie1
1Infection Control Program, King Hussein Cancer Center, Amman, Jordan.
Immunity, inflammation and disease
|September 29, 2023
概括
沙特阿拉伯和约旦的COVID-19疫苗接种率很高,国家,教育和年龄等因素影响了接种率. 有针对性的沟通可以进一步提高强剂量和儿科疫苗接种率.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 冠状病毒病2019 (COVID-19) 疫苗接种对于控制流行病和预防严重疾病至关重要.
- 评估疫苗的可接受性和影响疫苗接种的因素对于公共卫生战略至关重要.
研究的目的:
- 评估COVID-19疫苗和强剂量的可接受性.
- 确定影响接种COVID-19疫苗的意图及其强剂量的因素.
主要方法:
- 在沙特阿拉伯和约旦进行了一项横截面研究.
- 数据是通过自主管理的网络调查收集的,该调查于2022年5月至7月通过社交媒体分发.
主要成果:
- 在518名参与者中,超过54%的参与者已经接种了两剂COVID-19疫苗;42%的参与者已经接种了强剂,表明接受良好.
- 在国家,接种疫苗,打疫苗的意图和COVID-19感染之间发现了显著的关联.
- 对接种疫苗的态度与教育水平和年龄有关;与约旦人相比,沙特参与者对强剂的意愿更高.
结论:
- 该研究强调了人们对COVID-19疫苗接种和强剂量的积极态度和接受.
- 调查结果可以为有针对性的沟通策略提供信息,以提高疫苗和助推吸收率.
- 了解人口和国家特定因素是有效公共卫生干预的关键.
更多相关视频
相关概念视频
Vaccinations
44.6K
Overview
44.6K
Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396
Dose-Response Relationship: Selectivity and Specificity
6.9K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.9K
Dose-Response Relationship: Overview
3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
145
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145


